HDL-C比值与冠状动脉病变程度的相关性研究被引量：11

Research of correlation between LDL-C / HDL-C and TG / HDL-C ratio and severity of coronary heart disease

下载PDF

导出

摘要目的探讨LDL-C/HDL-C及TG/HDL-C比值与冠心病病变程度之间的相关性。方法分析169例冠脉造影检查确诊的冠心病患者(CHD组)及103例冠脉造影结果阴性者(对照组)LDL-C/HDL-C及TG/HDL-C比值与冠心病及其病变程度的关系。结果冠心病组患者LDL-C/HDL-C比值及TG/HDL-C比值水平及异常率均明显高于对照组,相关分析显示:LDLC/HDL-C及TG/HDL-C比值与冠心病及其病变程度均呈正相关,而前者预测意义更大。结论 LDL-C/HDL-C及TG/HDL-C比值可作为预测CHD的指标,且LDL-C/HDL-C比值水平与CHD相关性更强。 Objective To explore the correlation between LDL-C/HDL-C and TG/HDL-C ratio and severity of coronary heart disease. Methods LDL-C / HDL-C and TG / HDL-C ratio was analysed in 272 geriatric cases that underwent coronary angiography,who were positive in 169 geriatric patients( CHD group),and negative in 103 cases( normal control group). Results Both LDL-C / HDL-C and TG / HDL-C ratio and its abnormal rate were significantly higher in patients with CHD than those in the normal control group( P < 0. 05). Correlation analysis and multivariate regression analysis revealed that the ratio had significant positive correlation with coronary heart disease and its severity.Conclusion LDL-C / HDL-C and TG / HDL-C ratio is a good predictive index for CHD. Compared to TG / HDL-C ratio,LDL-C / HDL-C ratio reveals stronger correlation with CHD.

作者丁超文小平李荣成

机构地区安徽省六安市立医院心血管内科第三病区

出处《安徽医学》 2015年第1期75-77,共3页 Anhui Medical Journal

关键词冠心病低密度脂蛋白胆固醇高密度脂蛋白胆固醇三酰甘油心血管风险 Coronary heart disease Low density lipoprotein cholesterol High density lipoprotein cholesterol Triglyceride Cardio-vascular risk

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1Uthoff H,Staub D,Socrates T,Meyerhans A,Bundi B,Schmid H P,Frauchiger B.PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis. VASA. Zeitschrift für Gef?sskrankheiten. Journal for vascular diseases . 2010
2Kasai T,Miyauchi K,Yanagisawa N,et al.Mortality risk of triglyceride levels in patients with coronary artery disease. Heart . 2013
3Boumaiza Imen,Omezzine Asma,Rejeb Jihene,Rebhi Lamia,Kalboussi Nesrine,Ben Rejeb Nabila,Nabli Naoufel,Ben Abdelaziz Ahmed,Boughazala Essia,Bouslama Ali.Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients. Metabolic syndrome and related disorders . 2010
4Di Angelantonio E.,Sarwar N.,Perry P.,Kaptoge S.,Ray K.K.,Thompson A.,Wood A.M.,Danesh J.,Lewington S.,Collins R.,Sattar N.,Packard C.J.,Thompson S.G.Major lipids, apolipoproteins, and risk of vascular disease. JAMA - Journal of the American Medical Association . 2009
5赵水平.高甘油三酯与冠心病风险的相关性[J].中华心血管病杂志,2011,39(9):789-790. 被引量：18
6刘梅颜,郭丹杰,胡大一,徐成斌,崔永东.LDL-C/HDL-C及TG/HDL-C比值对冠心病的预测价值的评价[J].中国医刊,2002,37(5):32-34. 被引量：19
7赵尚敏,张明,霍海洋,何青.甘油三酯/高密度脂蛋白胆固醇比值对老年冠心病诊断价值的探讨[J].心血管康复医学杂志,2000,9(2):15-17. 被引量：9

二级参考文献18

1徐成斌.冠心病防治在调脂领域的某些进展与动向.心脑血管疾病危险因素控制学术研讨会[M].,2001.7-10.
2Assmann G,Schulte H,Cullen P,et al.Assessing risk of myocardial infarction and stroke:new data from the prospective cardiovascular Münster (PROCAM) study. Eur J Clin Invest,2007,37:925-932.
3Sarwar N,Danesh J,Eiriksdottir G,et al.Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.Circulation,2007,115:450-458.
4Emerging Risk Factors Collaboration,Di Angelantonio E,Sarwar N,et al. Major lipids,apolipoproteins,and risk of vascular disease.JAMA,2009,302:1993-2000.
5Vine DF,Takechi R,Russell JC,et al.Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.Atherosclerosis,2007,190:282-290.
6Weinstein MM,Yin L,Tu Y,et al.Chylomicronemia elicits atherosclerosis in mice-brief report.Arterioscler Thromb Vasc Biol,2010,30:20-23.
7Liu L,Wen T,Zheng XY,et al.Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism. Atheroeclerosis,2009,202:405-414.
8Keech A,Simes RJ, Barter P,et al.Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.Lancet,2005,366:1849-1861.
9Jialal I, Amess W, Kaur M, et al. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep,2010,10:316-320.
10Miller M,Stone NJ,Ballantyne C,et al.Triglycerides and cardiovascular disease:a scientific statement from the american heart association.Circulation,2011,123:2292-2333.